OVERVIEW

Improving Outcomes in Schizophrenia: Advances in Treatment & Management is organized by Specialty Pharma Education Center (SPEC).

Available Until: 8/20/2022

Accreditation:
Pharmacist continuing education credit
Specialty Pharma Education Center (SPEC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 2.0 hours (0.20CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test (score of 70% or higher). Participants will have 3 opportunities to pass the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

Accreditation Period: August 20, 2019 - August 20, 2022

Nursing continuing education credit
Educational Review Systems is an approved provider of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Provider # 5-115. This program is approved for 2.0 hours of continuing nursing education.

Accreditation Period: August 25, 2019 - August 25, 2021

Learning Objectives:
After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Psychiatric Pharmacists, Psychiatric Nurses and Nurses
• Discuss the neurotoxic effects of recurrent psychotic episodes on the brain to better comprehend the need for early intervention in schizophrenia
• Recognize available long-acting injectable (LAI) formulations of antipsychotic agents and their safety and efficacy
• Identify potential advantages and drawbacks of LAIs
• Describe factors associated with poor medication adherence in patients with schizophrenia and strategies to manage these issues to improve outcomes